Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

18.69 +0.84 (+4.71%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,557,092
Open 17.80
Bid (Size) 18.67 (1)
Ask (Size) 18.70 (21)
Prev. Close 17.85
Today's Range 17.36 - 18.73
52wk Range 5.650 - 25.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Where Does Hims & Hers Stock Go From Here?
Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright? 
Via The Motley Fool
Exposures Product Safety
2 Incredibly Cheap Growth Stocks to Buy Right Now
Look beyond the stock price at the business when shares are volatile. 
Via The Motley Fool

Performance

YTD
+93.88%
+93.88%
1 Month
+18.14%
+18.14%
3 Month
-18.17%
-18.17%
6 Month
+41.38%
+41.38%
1 Year
+199.04%
+199.04%

More News

Read More
2 No-Brainer Growth Stocks to Buy With $500 Right Now
Via The Motley Fool
What Is Going On With Hims & Hers Stock?
Via The Motley Fool
Top 3 Stocks with Explosive Call Option Activity: What to Watch
Via MarketBeat
How Is The Market Feeling About Hims & Hers Health?
Via Benzinga
Deep Dive Into Hims & Hers Health Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
Via Benzinga
Exposures Product Safety
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?
Via MarketBeat
Topics Stocks
Exposures US Equities
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
Via Benzinga
Hims & Hers Health Stock Is Rising Monday: What's Going On?
Via Benzinga
Topics Stocks
Exposures US Equities
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
Via Benzinga
Exposures Product Safety
Massive News for Hims & Hers Stock: The Truth About Today's Move
Via The Motley Fool
2 Winning Growth Stocks That Are Screaming Buys Right Now
Via The Motley Fool
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
Via Benzinga
Hims & Hers Health Stock Is Tumbling Thursday: Here's Why
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer
Via The Motley Fool
Hims & Hers To Offer Access To Compounded Diabetes And Weight Loss Drugs For Just $99/Month To Certain Professional Personnel
Via Benzinga
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
From Hims & Hers
Via Business Wire
Hims & Hers Acquisition: How Innovation Will Flourish
Via The Motley Fool
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
Via The Motley Fool
Hims & Hers Stock Pops After Massive Acquisition
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.